Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution.

Pernas S, Petit A, Climent F, Paré L, Perez-Martin J, Ventura L, Bergamino M, Galván P, Falo C, Morilla I, Fernandez-Ortega A, Stradella A, Rey M, Garcia-Tejedor A, Gil-Gil M, Prat A.

Front Oncol. 2019 Sep 25;9:967. doi: 10.3389/fonc.2019.00967. eCollection 2019.

2.

PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution.

Pernas S, Petit A, Climent F, Paré L, Perez-Martin J, Ventura L, Bergamino M, Galván P, Falo C, Morilla I, Fernandez-Ortega A, Stradella A, Rey M, Garcia-Tejedor A, Gil-Gil M, Prat A.

Front Oncol. 2019 Aug 6;9:707. doi: 10.3389/fonc.2019.00707. eCollection 2019. Erratum in: Front Oncol. 2019 Sep 25;9:967.

3.

Systematic Review and Meta-Analysis of Randomized, Controlled Trials on Preoperative Physical Exercise Interventions in Patients with Non-Small-Cell Lung Cancer.

Rosero ID, Ramírez-Vélez R, Lucia A, Martínez-Velilla N, Santos-Lozano A, Valenzuela PL, Morilla I, Izquierdo M.

Cancers (Basel). 2019 Jul 5;11(7). pii: E944. doi: 10.3390/cancers11070944. Review.

4.

Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy.

Zuazo M, Arasanz H, Fernández-Hinojal G, García-Granda MJ, Gato M, Bocanegra A, Martínez M, Hernández B, Teijeira L, Morilla I, Lecumberri MJ, Fernández de Lascoiti A, Vera R, Kochan G, Escors D.

EMBO Mol Med. 2019 Jul;11(7):e10293. doi: 10.15252/emmm.201910293. Epub 2019 Jun 6.

5.

Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients.

Cuyàs E, Fernández-Arroyo S, Buxó M, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Verdura S, Brunet J, López-Bonet E, Garcia M, Saidani S, Joven J, Martin-Castillo B, Menendez JA.

Aging (Albany NY). 2019 May 9;11(9):2874-2888. doi: 10.18632/aging.101960.

6.

PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer.

Bocanegra A, Fernandez-Hinojal G, Zuazo-Ibarra M, Arasanz H, Garcia-Granda MJ, Hernandez C, Ibañez M, Hernandez-Marin B, Martinez-Aguillo M, Lecumberri MJ, Fernandez de Lascoiti A, Teijeira L, Morilla I, Vera R, Escors D, Kochan G.

Int J Mol Sci. 2019 Apr 2;20(7). pii: E1631. doi: 10.3390/ijms20071631.

7.

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin.

Cuyàs E, Buxó M, Ferri Iglesias MJ, Verdura S, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Joven J, Brunet J, López-Bonet E, Garcia M, Saidani S, Queralt Moles X, Martin-Castillo B, Menendez JA.

Front Oncol. 2019 Mar 28;9:193. doi: 10.3389/fonc.2019.00193. eCollection 2019.

8.

A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study.

Martin-Castillo B, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Stradella A, Morilla I, Viñas G, Cortés J, Cuyàs E, Verdura S, Fernández-Ochoa Á, Fernández-Arroyo S, Segura-Carretero A, Joven J, Pérez E, Bosch N, Garcia M, López-Bonet E, Saidani S, Buxó M, Menendez JA.

Oncotarget. 2018 Nov 2;9(86):35687-35704. doi: 10.18632/oncotarget.26286. eCollection 2018 Nov 2.

9.

Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.

Ruiz de Garibay G, Herranz C, Llorente A, Boni J, Serra-Musach J, Mateo F, Aguilar H, Gómez-Baldó L, Petit A, Vidal A, Climent F, Hernández-Losa J, Cordero Á, González-Suárez E, Sánchez-Mut JV, Esteller M, Llatjós R, Varela M, López JI, García N, Extremera AI, Gumà A, Ortega R, Plà MJ, Fernández A, Pernas S, Falo C, Morilla I, Campos M, Gil M, Román A, Molina-Molina M, Ussetti P, Laporta R, Valenzuela C, Ancochea J, Xaubet A, Casanova Á, Pujana MA.

PLoS One. 2018 Nov 12;13(11):e0207586. doi: 10.1371/journal.pone.0207586. eCollection 2018.

10.

Colonic MicroRNA Profiles, Identified by a Deep Learning Algorithm, That Predict Responses to Therapy of Patients With Acute Severe Ulcerative Colitis.

Morilla I, Uzzan M, Laharie D, Cazals-Hatem D, Denost Q, Daniel F, Belleannee G, Bouhnik Y, Wainrib G, Panis Y, Ogier-Denis E, Treton X.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):905-913. doi: 10.1016/j.cgh.2018.08.068. Epub 2018 Sep 14.

PMID:
30223112
11.

In silico prediction of targets for anti-angiogenesis and their in vitro evaluation confirm the involvement of SOD3 in angiogenesis.

García-Vilas JA, Morilla I, Bueno A, Martínez-Poveda B, Medina MÁ, Ranea JAG.

Oncotarget. 2018 Apr 3;9(25):17349-17367. doi: 10.18632/oncotarget.24693. eCollection 2018 Apr 3.

12.

Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance.

Ruiz de Garibay G, Mateo F, Stradella A, Valdés-Mas R, Palomero L, Serra-Musach J, Puente DA, Díaz-Navarro A, Vargas-Parra G, Tornero E, Morilla I, Farré L, Martinez-Iniesta M, Herranz C, McCormack E, Vidal A, Petit A, Soler T, Lázaro C, Puente XS, Villanueva A, Pujana MA.

Dis Model Mech. 2018 May 18;11(5). pii: dmm032292. doi: 10.1242/dmm.032292.

13.

Geriatric oncology in Spain: survey results and analysis of the current situation.

Gironés R, Morilla I, Guillen-Ponce C, Torregrosa MD, Paredero I, Bustamante E, Del Barco S, Soler G, Losada B, Visa L, Llabrés E, Fox B, Firvida JL, Blanco R, Antonio M, Aparisi F, Pi-Figueras M, Gonzalez-Flores E, Molina-Garrido MJ, Saldaña J; Spanish Working Group on Geriatric Oncology of the Spanish Society of Medical Oncology (SEOM).

Clin Transl Oncol. 2018 Aug;20(8):1087-1092. doi: 10.1007/s12094-017-1813-0. Epub 2017 Dec 11.

14.

Male sex in houseflies is determined by Mdmd, a paralog of the generic splice factor gene CWC22.

Sharma A, Heinze SD, Wu Y, Kohlbrenner T, Morilla I, Brunner C, Wimmer EA, van de Zande L, Robinson MD, Beukeboom LW, Bopp D.

Science. 2017 May 12;356(6338):642-645. doi: 10.1126/science.aam5498.

PMID:
28495751
15.

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population.

Gómez-Miragaya J, Palafox M, Paré L, Yoldi G, Ferrer I, Vila S, Galván P, Pellegrini P, Pérez-Montoyo H, Igea A, Muñoz P, Esteller M, Nebreda AR, Urruticoechea A, Morilla I, Pernas S, Climent F, Soler-Monso MT, Petit A, Serra V, Prat A, González-Suárez E.

Stem Cell Reports. 2017 May 9;8(5):1392-1407. doi: 10.1016/j.stemcr.2017.03.026. Epub 2017 Apr 27.

16.

Social cognition in bipolar disorder: Focus on emotional intelligence.

Varo C, Jimenez E, Solé B, Bonnín CM, Torrent C, Valls E, Morilla I, Lahera G, Martínez-Arán A, Vieta E, Reinares M.

J Affect Disord. 2017 Aug 1;217:210-217. doi: 10.1016/j.jad.2017.04.012. Epub 2017 Apr 9.

PMID:
28427032
17.

Mathematical deconvolution uncovers the genetic regulatory signal of cancer cellular heterogeneity on resistance to paclitaxel.

Morilla I, Ranea JA.

Mol Genet Genomics. 2017 Aug;292(4):857-869. doi: 10.1007/s00438-017-1316-2. Epub 2017 Apr 6.

PMID:
28386641
18.

High cognitive reserve in bipolar disorders as a moderator of neurocognitive impairment.

Grande I, Sanchez-Moreno J, Sole B, Jimenez E, Torrent C, Bonnin CM, Varo C, Tabares-Seisdedos R, Balanzá-Martínez V, Valls E, Morilla I, Carvalho AF, Ayuso-Mateos JL, Vieta E, Martinez-Aran A.

J Affect Disord. 2017 Jan 15;208:621-627. doi: 10.1016/j.jad.2016.10.012. Epub 2016 Oct 18.

PMID:
28029429
19.

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

Mateo F, Arenas EJ, Aguilar H, Serra-Musach J, de Garibay GR, Boni J, Maicas M, Du S, Iorio F, Herranz-Ors C, Islam A, Prado X, Llorente A, Petit A, Vidal A, Català I, Soler T, Venturas G, Rojo-Sebastian A, Serra H, Cuadras D, Blanco I, Lozano J, Canals F, Sieuwerts AM, de Weerd V, Look MP, Puertas S, García N, Perkins AS, Bonifaci N, Skowron M, Gómez-Baldó L, Hernández V, Martínez-Aranda A, Martínez-Iniesta M, Serrat X, Cerón J, Brunet J, Barretina MP, Gil M, Falo C, Fernández A, Morilla I, Pernas S, Plà MJ, Andreu X, Seguí MA, Ballester R, Castellà E, Nellist M, Morales S, Valls J, Velasco A, Matias-Guiu X, Figueras A, Sánchez-Mut JV, Sánchez-Céspedes M, Cordero A, Gómez-Miragaya J, Palomero L, Gómez A, Gajewski TF, Cohen EEW, Jesiotr M, Bodnar L, Quintela-Fandino M, López-Bigas N, Valdés-Mas R, Puente XS, Viñals F, Casanovas O, Graupera M, Hernández-Losa J, Ramón Y Cajal S, García-Alonso L, Saez-Rodriguez J, Esteller M, Sierra A, Martín-Martín N, Matheu A, Carracedo A, González-Suárez E, Nanjundan M, Cortés J, Lázaro C, Odero MD, Martens JWM, Moreno-Bueno G, Barcellos-Hoff MH, Villanueva A, Gomis RR, Pujana MA.

Oncogene. 2017 May 11;36(19):2737-2749. doi: 10.1038/onc.2016.427. Epub 2016 Dec 19.

20.

Early group psychoeducation for bipolar disorder.

Vieta E, Morilla I.

Lancet Psychiatry. 2016 Nov;3(11):1000-1001. doi: 10.1016/S2215-0366(16)30303-0. Epub 2016 Sep 27. No abstract available.

PMID:
27688022
21.

Exploring the interactions of the RAS family in the human protein network and their potential implications in RAS-directed therapies.

Bueno A, Morilla I, Diez D, Moya-Garcia AA, Lozano J, Ranea JA.

Oncotarget. 2016 Nov 15;7(46):75810-75826. doi: 10.18632/oncotarget.12416.

22.

Integrative Network-based Analysis of Colonic Detoxification Gene Expression in Ulcerative Colitis According to Smoking Status.

Ding YP, Ladeiro Y, Morilla I, Bouhnik Y, Marah A, Zaag H, Cazals-Hatem D, Seksik P, Daniel F, Hugot JP, Wainrib G, Tréton X, Ogier-Denis E.

J Crohns Colitis. 2017 Apr 1;11(4):474-484. doi: 10.1093/ecco-jcc/jjw179.

PMID:
27702825
23.

Increased Proliferation of the Ileal Epithelium as a Remote Effect of Ulcerative Colitis.

Sedghi S, Barreau F, Morilla I, Montcuquet N, Cazals-Hatem D, Pedruzzi E, Rannou E, Tréton X, Hugot JP, Ogier-Denis E, Daniel F.

Inflamm Bowel Dis. 2016 Oct;22(10):2369-81. doi: 10.1097/MIB.0000000000000871.

PMID:
27598740
24.

Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.

Ruiz de Garibay G, Herranz C, Llorente A, Boni J, Serra-Musach J, Mateo F, Aguilar H, Gómez-Baldó L, Petit A, Vidal A, Climent F, Hernández-Losa J, Cordero Á, González-Suárez E, Sánchez-Mut JV, Esteller M, Llatjós R, Varela M, López JI, García N, Extremera AI, Gumà A, Ortega R, Plà MJ, Fernández A, Pernas S, Falo C, Morilla I, Campos M, Gil M, Román A, Molina-Molina M, Ussetti P, Laporta R, Valenzuela C, Ancochea J, Xaubet A, Casanova Á, Pujana MA.

PLoS One. 2015 Jul 13;10(7):e0132546. doi: 10.1371/journal.pone.0132546. eCollection 2015. Erratum in: PLoS One. 2018 Nov 12;13(11):e0207586.

25.

FUN-L: gene prioritization for RNAi screens.

Lees JG, Hériché JK, Morilla I, Fernández JM, Adler P, Krallinger M, Vilo J, Valencia A, Ellenberg J, Ranea JA, Orengo C.

Bioinformatics. 2015 Jun 15;31(12):2052-3. doi: 10.1093/bioinformatics/btv073. Epub 2015 Feb 8.

PMID:
25667547
26.

Protein-protein interfaces from cytochrome c oxidase I evolve faster than nonbinding surfaces, yet negative selection is the driving force.

Aledo JC, Valverde H, Ruíz-Camacho M, Morilla I, López FD.

Genome Biol Evol. 2014 Oct 29;6(11):3064-76. doi: 10.1093/gbe/evu240.

27.

Integration of biological data by kernels on graph nodes allows prediction of new genes involved in mitotic chromosome condensation.

Hériché JK, Lees JG, Morilla I, Walter T, Petrova B, Roberti MJ, Hossain MJ, Adler P, Fernández JM, Krallinger M, Haering CH, Vilo J, Valencia A, Ranea JA, Orengo C, Ellenberg J.

Mol Biol Cell. 2014 Aug 15;25(16):2522-36. doi: 10.1091/mbc.E13-04-0221. Epub 2014 Jun 18.

28.

Metaplastic carcinoma of the breast with chondroid differentiation (matrix-producing carcinoma): study of the diagnostic cost-effectiveness of fine-needle aspiration biopsy and needle core biopsy.

Soler Monsó MT, Català I, Terricabras M, Petit A, Climent F, Pérez-Casanovas L, Gumà A, Morilla I.

Acta Cytol. 2014;58(1):9-14. doi: 10.1159/000354383. Epub 2013 Nov 15.

PMID:
24246799
29.

Eribulin mesylate in breast cancer.

Verdaguer H, Morilla I, Urruticoechea A.

Womens Health (Lond). 2013 Nov;9(6):517-26. doi: 10.2217/whe.13.61.

PMID:
24161305
30.

Uncovering the molecular machinery of the human spindle--an integration of wet and dry systems biology.

Rojas AM, Santamaria A, Malik R, Jensen TS, Körner R, Morilla I, de Juan D, Krallinger M, Hansen DA, Hoffmann R, Lees J, Reid A, Yeats C, Wehner A, Elowe S, Clegg AB, Brunak S, Nigg EA, Orengo C, Valencia A, Ranea JA.

PLoS One. 2012;7(3):e31813. doi: 10.1371/journal.pone.0031813. Epub 2012 Mar 9.

31.

The function of histamine receptor H4R in the brain revealed by interaction partners.

Moya-Garcia AA, Rodriguez CE, Morilla I, Sanchez-Jimenez F, Ranea JA.

Front Biosci (Schol Ed). 2011 Jun 1;3:1058-66.

PMID:
21622255
32.

Systematic computational prediction of protein interaction networks.

Lees JG, Heriche JK, Morilla I, Ranea JA, Orengo CA.

Phys Biol. 2011 Jun;8(3):035008. doi: 10.1088/1478-3975/8/3/035008. Epub 2011 May 13.

PMID:
21572181
33.

Finding the "dark matter" in human and yeast protein network prediction and modelling.

Ranea JA, Morilla I, Lees JG, Reid AJ, Yeats C, Clegg AB, Sanchez-Jimenez F, Orengo C.

PLoS Comput Biol. 2010 Sep 23;6(9). pii: e1000945. doi: 10.1371/journal.pcbi.1000945.

34.

Assessment of protein domain fusions in human protein interaction networks prediction: application to the human kinetochore model.

Morilla I, Lees JG, Reid AJ, Orengo C, Ranea JA.

N Biotechnol. 2010 Dec 31;27(6):755-65. doi: 10.1016/j.nbt.2010.09.005. Epub 2010 Sep 17.

PMID:
20851221
35.

Muscle metastasis of low-grade endometrial carcinoma seven years after diagnosis: a case report.

Oaknin A, Barretina MP, Morilla I.

Eur J Gynaecol Oncol. 2010;31(1):114-6.

PMID:
20349796
36.

Secondary orbital metastases from cutaneous melanoma.

Conill C, Morilla I, Malvehy J, Toscas I, Puig S, Pujol T.

Melanoma Res. 2004 Oct;14(5):437-8. No abstract available.

PMID:
15457105
37.

Conservative treatment in noninvasive breast cancer.

Rodríguez N, Sanz X, Algara M, Foro P, Auñón C, Morilla I, Reig A, Ferrer F.

Tumori. 2004 Jan-Feb;90(1):17-21.

PMID:
15143965
38.

Radiation therapy as a curative treatment in extraocular sebaceous carcinoma.

Conill C, Toscas I, Morilla I, Mascaró JM Jr.

Br J Dermatol. 2003 Aug;149(2):441-2. No abstract available.

PMID:
12932271

Supplemental Content

Loading ...
Support Center